Aldeyra Therapeutics, Inc.
ALDX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$8 | -$10 | -$10 | -$16 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $1 |
| Change in WC | -$2 | $1 | -$5 | $3 |
| Other Non-Cash | $2 | -$0 | $2 | -$0 |
| Operating Cash Flow | -$7 | -$9 | -$12 | -$12 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$25 | -$16 | -$22 |
| Inv. Sales/Matur. | $25 | $24 | $23 | $20 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $25 | -$1 | $7 | -$2 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$0 |
| Stock Issued | $0 | $0 | $1 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $0 | $0 | $1 | $0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $18 | -$9 | -$4 | -$14 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $41 | $50 | $55 | $68 |
| End Cash | $59 | $41 | $50 | $55 |
| Free Cash Flow | -$7 | -$9 | -$12 | -$12 |